© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
April 21, 2020
Digital technologies may have the best opportunity to change how trials are conducted for years to come.
FDA Approves Dupilumab as the First Medical Treatment for Prurigo Nodularis
Dupilumab Leads to Favorable Outcomes for Chronic Rhinosinusitis
Review Examines Different Ways to Reduce Costs for Atopic Dermatitis Treatment